Not intended for injection, ingestion, or topical use
Eli Lilly is also enrolling patients in its own trial, TREASURE-CKD , to see if tirzepatide (marketed under the names Mounjaro for type 2 diabetes and Zepbound for obesity) can treat CKD in people with obesity or type 2 diabetes
However, its use is restricted to certified opioid treatment programs (OTPs), and it carries a risk of misuse, requiring close supervision
Golfers could practice putting and chipping before resuming full swings
Imagine reporting outcomes not just in disease prevented but disease reversed. Imagine studies comparing relapse vs durable remission
Factors like injection depth, skin temperature, and physical activity level have far more influence on absorption speed than your circadian rhythm